/wp-content/uploads/4dmt_logo.svg00Adam Chalemian/wp-content/uploads/4dmt_logo.svgAdam Chalemian2025-02-06 11:00:212025-02-06 11:16:20Non-clinical Evaluation of 4D-310 in Combination With Rituximab/Sirolimus: A Translational Study to Support Adoption of a Novel Prophylactic Immunomodulation Regimen in Clinical Trials in Adults with Fabry Disease
/wp-content/uploads/4dmt_logo.svg00Adam Chalemian/wp-content/uploads/4dmt_logo.svgAdam Chalemian2025-02-06 10:57:142025-02-06 11:16:27Phase 1/2 Clinical Trial Evaluating 4d-310 In Adults With Fabry Disease Cardiomyopathy: Interim Analysis of Cardiac and Safety Outcomes in Patients with 21-42 Months of Follow Up (Poster)
/wp-content/uploads/4dmt_logo.svg00Adam Chalemian/wp-content/uploads/4dmt_logo.svgAdam Chalemian2025-02-06 10:55:202025-02-06 11:16:34Phase 1/2 Clinical Trial Evaluating 4d-310 In Adults With Fabry Disease Cardiomyopathy: Interim Analysis of Cardiac and Safety Outcomes in Patients with 21-42 Months of Follow Up
/wp-content/uploads/4dmt_logo.svg00Adam Chalemian/wp-content/uploads/4dmt_logo.svgAdam Chalemian2025-02-06 10:52:532025-02-06 11:16:41Non-clinical Evaluation of 4D-310 in Combination With Rituximab/Sirolimus: A Translational Study to Support Adoption of a Novel Prophylactic Immunomodulation Regimen in Clinical Trials in Adults with Fabry Disease (Poster)
/wp-content/uploads/4dmt_logo.svg00Erik Allison/wp-content/uploads/4dmt_logo.svgErik Allison2024-12-11 14:00:422024-12-11 14:14:40Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies
/wp-content/uploads/4dmt_logo.svg00Erik Allison/wp-content/uploads/4dmt_logo.svgErik Allison2024-09-17 17:06:282024-09-17 20:16:43Extended Follow-Up in the PRISM Clinical Trial Evaluating 4D-150 in Adults with Neovascular Age-related Macular Degeneration
/wp-content/uploads/4dmt_logo.svg00Erik Allison/wp-content/uploads/4dmt_logo.svgErik Allison2024-07-15 08:40:252024-07-15 10:07:08Phase 2 Population Extension Cohort in the PRISM Trial Evaluating 4D-150 in Adults With Neovascular Age-related Macular Degeneration
/wp-content/uploads/4dmt_logo.svg00Erik Allison/wp-content/uploads/4dmt_logo.svgErik Allison2024-06-06 15:18:302024-06-07 11:48:4824-week Results from the Randomized Phase 2 Dose Expansion Stage of the PRISM Trial Evaluating 4D-150 in High Need nAMD Patients: Injection-free Patient Analyses
/wp-content/uploads/4dmt_logo.svg00David Anderson/wp-content/uploads/4dmt_logo.svgDavid Anderson2024-06-05 14:36:312024-06-06 15:18:27CFTR Transgene Expression in Airway Epithelial Cells Following Aerosolized Administration of the AAV-based Gene Therapy 4D-710 to Adults with Cystic Fibrosis Lung Disease